Clinical Trials Browser

Phase 2/3 × Memantine × 1 year × Clear all

NCT07504198 2026-03-31

Neuroprotection of Memantine and Rosuvastatin

Phase 2/3 Not yet recruiting

Peripheral Nervous System Diseases

NCT06007846 2025-09-30

A Prospective Study of Memantine in Patients With Cirrhosis and Liver Cancer

Phase 2/3 Recruiting

Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular